You are here


Found 778 results
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Sanz MM, Proytcheva M, Ellis NA, Holloman WK, German J.  2000.  BLM, the Bloom's syndrome protein, varies during the cell cycle in its amount, distribution, and co-localization with other nuclear proteins.. Cytogenet Cell Genet. 91(1-4):217-23.
Sartori A, Ma X, Gri G, Showe L, Benjamin D, Trinchieri G.  1997.  Interleukin-12: an immunoregulatory cytokine produced by B cells and antigen-presenting cells.. Methods. 11(1):116-27.
Sawaya R, Schwer B, Shuman S.  2003.  Genetic and biochemical analysis of the functional domains of yeast tRNA ligase.. J Biol Chem. 278(45):43928-38.
Sawunyama P, Jackson M, Bailey GW.  2001.  Interactions of Methyl Orange with Cyclodextrin/Sodium-Montmorillonite Systems Probed by UV-Visible Spectroscopy.. J Colloid Interface Sci. 237(2):153-157.
Schirmer F, Ehrt S, Hillen W.  1997.  Expression, inducer spectrum, domain structure, and function of MopR, the regulator of phenol degradation in Acinetobacter calcoaceticus NCIB8250.. J Bacteriol. 179(4):1329-36.
Schlitzer A, Zhang W, Song M, Ma X.  2018.  Recent advances in understanding dendritic cell development, classification, and phenotype.. F1000Res. 7
Schnappinger D.  2015.  Genetic Approaches to Facilitate Antibacterial Drug Development.. Cold Spring Harb Perspect Med. 5(7):a021139.
Schnappinger D, Geissdörfer W, Sizemore C, Hillen W.  1995.  Extracellular expression of native human anti-lysozyme fragments in Staphylococcus carnosus.. FEMS Microbiol Lett. 129(2-3):121-7.
Schnappinger D, Ehrt S.  2014.  Regulated Expression Systems for Mycobacteria and Their Applications.. Microbiol Spectr. 2(1)
Schnappinger D, Schubert P, Pfleiderer K, Hillen W.  1998.  Determinants of protein-protein recognition by four helix bundles: changing the dimerization specificity of Tet repressor.. EMBO J. 17(2):535-43.
Schnappinger D, Hillen W.  1996.  Tetracyclines: antibiotic action, uptake, and resistance mechanisms.. Arch Microbiol. 165(6):359-69.
Schnappinger D, Ehrt S.  2014.  Regulated Expression Systems for Mycobacteria and Their Applications.. Microbiol Spectr. 2(1):MGM2-0018-2013.
Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, Dolganov G, Efron B, Butcher PD, Nathan C et al..  2003.  Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment.. J Exp Med. 198(5):693-704.
Schnappinger D.  2007.  Genomics of host-pathogen interactions.. Prog Drug Res. 64:311,313-43.
Schnappinger D, Schoolnik GK, Ehrt S.  2006.  Expression profiling of host pathogen interactions: how Mycobacterium tuberculosis and the macrophage adapt to one another.. Microbes Infect. 8(4):1132-40.
Schnappinger D, Ehrt S.  2006.  Introduction: genomic approaches in infectious diseases.. Microbes Infect. 8(6):1611-2.
Schnappinger D, Ehrt S.  2016.  A broader spectrum of tuberculosis.. Nat Med. 22(10):1076-1077.
Schnappinger D, O'Brien KM, Ehrt S.  2015.  Construction of conditional knockdown mutants in mycobacteria.. Methods Mol Biol. 1285:151-75.
Schnappinger D, Schubert P, Berens C, Pfleiderer K, Hillen W.  1999.  Solvent-exposed residues in the Tet repressor (TetR) four-helix bundle contribute to subunit recognition and dimer stability.. J Biol Chem. 274(10):6405-10.
Schneider S, Campodonico E, Schwer B.  2004.  Motifs IV and V in the DEAH box splicing factor Prp22 are important for RNA unwinding, and helicase-defective Prp22 mutants are suppressed by Prp8.. J Biol Chem. 279(10):8617-26.
Schneider S, Hotz H-R, Schwer B.  2002.  Characterization of dominant-negative mutants of the DEAH-box splicing factors Prp22 and Prp16.. J Biol Chem. 277(18):15452-8.
Schneider S, Schwer B.  2001.  Functional domains of the yeast splicing factor Prp22p.. J Biol Chem. 276(24):21184-91.
Schoggins JW, Nociari M, Philpott N, Falck-Pedersen E.  2005.  Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.. J Virol. 79(18):11627-37.
Schoggins JW, Falck-Pedersen E.  2006.  Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity.. J Virol. 80(21):10634-44.
Schoggins JW, Gall JGD, Falck-Pedersen E.  2003.  Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo.. J Virol. 77(2):1039-48.